{"cluster": 36, "subcluster": 16, "abstract_summ": "Given the similarities of clinical features and pathogenesis between toxic epidermal necrolysis (TEN) and COVID-19, we hypothesize that the application of etanercept, an inhibitor of TNF\u03b1, could attenuate disease progression in severe group COVID-19 patients by suppressing systemic auto-inflammatory responses.Influenza viruses, corona viruses and related pneumotropic viruses cause sickness and death partly by inducing a hyper-proinflammatory response by immune cells and cytokines in the host airway.ARDS is caused and sustained by an uncontrolled inflammatory activation characterized by a massive release of cytokines (cytokine storm), diffuse lung edema, inflammatory cell infiltraton and disseminated coagulation.This paper discusses the potential use of ET-traps for the COVID-19 pandemic, which previous studies have shown involves high cytokine levels.Data on the implication of cytokines in this disease and their effect on outcomes will support the design of more effective approaches to the management of COVID-19.Severe pneumonia which shares several of the features of acute respiratory distress syndrome (ARDS) is the main cause of morbidity and mortality in Coronavirus disease 19 (Covid\u201019) for which as of now there is no effective treatment.", "title_summ": "Classical drug digitoxin inhibits influenza cytokine storm, with implications for COVID-19 therapySARS-CoV-2 infection: the role of cytokines in COVID-19 diseaseA rationale for targeting the P2X7 receptor in Coronavirus disease 19 (Covid\u201019)TNF\u03b1 inhibitor may be effective for severe COVID-19: learning from toxic epidermal necrolysisET-traps as a potential treatment for COVID-19Targeting lymphocyte Kv1.3-channels to suppress cytokine storm in severe COVID-19: Can it be a novel therapeutic strategy?New intrigant possibility for prevention of coronavirus pneumonitis: natural purified polyphenols.", "title_abstract_phrases": "Classical drug digitoxin inhibits influenza cytokine storm, with implications for COVID-19 therapyInfluenza viruses, corona viruses and related pneumotropic viruses cause sickness and death partly by inducing a hyper-proinflammatory response by immune cells and cytokines in the host airway.Targeting lymphocyte Kv1.3-channels to suppress cytokine storm in severe COVID-19: Can it be a novel therapeutic strategy?In the midst of a pandemic, finding effective treatments for coronavirus disease 2019 (COVID-19) is the urgent issue.Given the similarities of clinical features and pathogenesis between toxic epidermal necrolysis (TEN) and COVID-19, we hypothesize that the application of etanercept, an inhibitor of TNF\u03b1, could attenuate disease progression in severe group COVID-19 patients by suppressing systemic auto-inflammatory responses.Data on the implication of cytokines in this disease and their effect on outcomes will support the design of more effective approaches to the management of COVID-19.A rationale for targeting the P2X7 receptor in Coronavirus disease 19 (Covid\u201019)Severe pneumonia which shares several of the features of acute respiratory distress syndrome (ARDS) is the main cause of morbidity and mortality in Coronavirus disease 19 (Covid\u201019) for which as of now there is no effective treatment.ARDS is caused and sustained by an uncontrolled inflammatory activation characterized by a massive release of cytokines (cytokine storm), diffuse lung edema, inflammatory cell infiltraton and disseminated coagulation."}